Results
1 -
10 of
41
(Click
here to explore results)
Successful Strategies for the Discovery of Antiviral Drugs, CHAPTER 13 Cobicistat and Ritonavir as Pharmacoenhancers for Antiviral Drugs . Lianhong Xu, Manoj C. Desai
, 2013
, Pages 451-481
Biocatalysis: An Industrial Perspective, CHAPTER 5 Bristol-Myers Squibb: Preparation of Chiral Intermediates for the Development of Drugs and APIs . Ramesh N. Patel
, 2018
, Pages 125-167
The Coronavirus Pandemic and the Future: Virology, Epidemiology, Translational Toxicology and Therapeutics, Volume 2, CHAPTER 1 In Silico Approaches for Drug Repurposing for SARS-CoV-2 Infection . Sudhir A. Kulkarni, Kundan Ingale
, 2022
, Volume 2
, Pages 1-80
Conference on Drug Design and Discovery Technologies, Enhancement of Atazanavir Solubility Using β-Cyclodextrin Based Nanosponges . D. N. Venkatesh
, 2020
, Pages 207-211
Biocatalysis: An Industrial Perspective, Contents
, 2018
, Pages P009-P020
Metabolism, Pharmacokinetics and Toxicity of Functional Groups: Impact of Chemical Building Blocks on ADMET, Chapter 9 Pharmacokinetics and Metabolism of Compounds that Mimic Enzyme Transition States . Iain Gardner, Chris Barber, Martin Howard, Aarti Sawant, Kenny Watson
, 2010
, Pages 390-459
Drug Design Strategies: Quantitative Approaches, Chapter 5 Contribution of Structure-Based Drug Design to the Discovery of Marketed drugs . Alexander A. Alex, David S. Millan
, 2012
, Pages 108-163
New Horizons in Predictive Drug Metabolism and Pharmacokinetics, CHAPTER 5 Non-Cytochrome P450 Enzymes and Glucuronidation . J. Matthew Hutzler, Michael A. Zientek
, 2016
, Pages 79-130
Drug Transporters: Volume 2: Recent Advances and Emerging Technologies, Chapter 5 Pharmacogenomics of Drug Transporters: Clinical Implications . Ichiro Ieiri
, 2016
, Volume 2
, Pages 114-142
Pharmaceutical Process Development: Current Chemical and Engineering Challenges, Chapter 1 Introduction . A. John Blacker, Mike T. Williams
, 2011
, Pages 1-14